128 results
Page 5 of 7
8-K
EX-99.1
n9t0djjj
6 May 19
Adaptimmune TRANSFORMING T CELL THERAPY Clinical and Business Update
8:11am
8-K
EX-99.1
c91bfc874hsf2h0
2 May 19
Other Events
7:10am
8-K/A
EX-99.1
58f7buloj351ggmtqg1
27 Feb 19
CORRECTING and REPLACING — Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
5:16pm
8-K
EX-99.1
l9lax3t3qs4yjxza
27 Feb 19
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
7:43am
CORRESP
9ydimwnalt 6uz
18 Oct 18
Correspondence with SEC
12:00am
8-K
EX-99.1
jujlf
15 Aug 18
Third Dosing Cohort to be initiated in MAGE-A4 SPEAR T-cell Basket Study After Favorable Review of Safety from One Billion Cell Dose Cohort
7:39am
8-K
6fwa10crrin
24 Jul 18
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
7:36am
8-K
EX-99.1
80qk mc7su31
24 Jul 18
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
7:36am
8-K
EX-99.1
uj9v3b5s6mxvza08
18 Jul 18
Other Events
5:01pm